Literature DB >> 28246438

Talimogene laherparepvec for melanoma.

.   

Abstract

Entities:  

Year:  2017        PMID: 28246438      PMCID: PMC5313250          DOI: 10.18773/austprescr.2016.094

Source DB:  PubMed          Journal:  Aust Prescr        ISSN: 0312-8008


× No keyword cloud information.
  3 in total

1.  Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.

Authors:  Robert H I Andtbacka; Howard L Kaufman; Frances Collichio; Thomas Amatruda; Neil Senzer; Jason Chesney; Keith A Delman; Lynn E Spitler; Igor Puzanov; Sanjiv S Agarwala; Mohammed Milhem; Lee Cranmer; Brendan Curti; Karl Lewis; Merrick Ross; Troy Guthrie; Gerald P Linette; Gregory A Daniels; Kevin Harrington; Mark R Middleton; Wilson H Miller; Jonathan S Zager; Yining Ye; Bin Yao; Ai Li; Susan Doleman; Ari VanderWalde; Jennifer Gansert; Robert S Coffin
Journal:  J Clin Oncol       Date:  2015-05-26       Impact factor: 44.544

2.  Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.

Authors:  Neil N Senzer; Howard L Kaufman; Thomas Amatruda; Mike Nemunaitis; Tony Reid; Gregory Daniels; Rene Gonzalez; John Glaspy; Eric Whitman; Kevin Harrington; Howard Goldsweig; Tracey Marshall; Colin Love; Robert Coffin; John J Nemunaitis
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

Review 3.  Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma.

Authors:  Howard L Kaufman; Carl E Ruby; Tasha Hughes; Craig L Slingluff
Journal:  J Immunother Cancer       Date:  2014-05-13       Impact factor: 13.751

  3 in total
  1 in total

1.  Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression.

Authors:  Hilal Bhat; Gregor Zaun; Thamer A Hamdan; Judith Lang; Tom Adomati; Rosa Schmitz; Sarah-Kim Friedrich; Michael Bergerhausen; Lamin B Cham; Fanghui Li; Murtaza Ali; Fan Zhou; Vishal Khairnar; Vikas Duhan; Tim Brandenburg; Yara Maria Machlah; Maximilian Schiller; Arshia Berry; Haifeng Xu; Jörg Vollmer; Dieter Häussinger; Beatrice Thier; Aleksandra A Pandyra; Dirk Schadendorf; Annette Paschen; Martin Schuler; Philipp A Lang; Karl S Lang
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.